This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Shilpa Medicare Limited. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Purohit Prashant: Innovator in Pharmaceutical Chemistry
Introduction
Purohit Prashant is a notable inventor based in Raichur, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds. His work has led to advancements that can potentially improve therapeutic outcomes in various medical conditions.
Latest Patents
Purohit Prashant holds 1 patent for his invention titled "Substantially pure vemurafenib and its salts." This patent relates to a process for the preparation of substantially pure propane-1-sulfonic acid-{3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide, commonly known as Vemurafenib. The invention also includes a process for preparing the trifluoro methane sulfonic acid salt of Vemurafenib, known as Vemurafenib triflate.
Career Highlights
Purohit Prashant is associated with Shilpa Medicare Limited, a company known for its focus on pharmaceutical innovations. His role in the company has allowed him to contribute to the development of new drugs and therapies that address critical health issues.
Collaborations
Purohit has collaborated with notable colleagues, including Chaturvedi Akshay Kant and Nagnnath Kokare. These collaborations have fostered a productive environment for innovation and research within the pharmaceutical sector.
Conclusion
Purohit Prashant's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in medicine. His patent on Vemurafenib showcases his commitment to advancing healthcare solutions. Through his work at Shilpa Medicare Limited, he continues to play a vital role in the development of effective therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile